logo
Common herbs like rosemary may have inspired a breakthrough Alzheimer's treatment

Common herbs like rosemary may have inspired a breakthrough Alzheimer's treatment

Euronews23-03-2025
ADVERTISEMENT
Researchers have found a compound derived from common herbs has successfully enhanced memory and brain density in mice, and could lead to new treatments for Alzheimer's.
A team from The Scripps Research Institute based in the US worked on a derivative of carnosic acid, a molecule found in rosemary and sage.
They synthesised a more stable derivative called diAcCA and then used it to treat mice modified to show Alzheimer's-like symptoms for three months.
The mice that received the new drug showed improved learning and memory skills as well as more synapses, the junctions where neurons connect and communicate with each other, according to the findings published in the journal
Antioxidants
.
The loss of synapses correlates strongly with cognitive decline.
The mice also showed less buildup of amyloid plaques and tau tangles, two harmful proteins among the hallmarks of Alzheimer's disease in humans.
Alzheimer's disease accounts for 70 per cent of dementia cases.
Related
Experimental drug may slow dementia onset for patients with rare genetic form of Alzheimer's
It poses a significant and growing burden across Europe, affecting approximately 7 million people today, with numbers projected to double to 14 million by 2030 due to its ageing population.
'By combating inflammation and oxidative stress with this diAcCA compound, we actually increased the number of synapses in the brain,' Stuart Lipton, a professor at Scripps Research and one of the study's authors,
said in a statement.
'We also took down other misfolded or aggregated proteins such as phosphorylated-tau and amyloid-β, which are thought to trigger Alzheimer's disease and serve as biomarkers of the disease process,' he added.
An anti-oxydant molecule
Carnosic acid is an antioxidant and an anti-inflammatory but it has a very short shelf-life, while the diAcCA can be taken orally before being converted into carnosic acid in the stomach and entering the bloodstream.
The amount in the blood of the test mice was 20 per cent higher with the new method compared to usual ingestion of carnosic acid.
'We did multiple different tests of memory, and they were all improved with the drug,' Lipton said.
'And it didn't just slow down the decline; it improved virtually back to normal,' he added.
The researchers added that the mice tolerated diAcCA well.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Canada needs 'bold ambition' to poach top US researchers
Canada needs 'bold ambition' to poach top US researchers

France 24

time18-06-2025

  • France 24

Canada needs 'bold ambition' to poach top US researchers

But to succeed, Canada will need to summon something it has at times lacked, namely "bold ambition," the head of the country's largest hospital chain told AFP. Trump's funding cuts for scientific research are freeing up talent and "creating a once-in-a-lifetime opportunity" to recruit, said Kevin Smith, the chief executive of Toronto's University Health Network (UHN). To seize that opportunity, Canada has to ditch its traditional "incrementalist" approach, Smith added. "Let's not say good enough is good enough. Let's say excellent is where we need to go." Experts say Trump's policies could trigger a tectonic shift in the global competition for the world's brightest minds. For decades, deep-pocketed US universities backed by federal support have scooped up talent, including in biomedical research. But Trump's administration has already slashed billions of dollars in research grants affecting various institutions, including most notably Harvard University. Programs affected by the National Institutes of Health's cuts include studies on gender, the health effects of global warming, Alzheimer's disease, and cancer. France and the European Union are already trying to woo disgruntled US researchers. European Commission head Ursula von der Leyen said last month that the EU would launch a new incentives package worth 500 million euros ($577 million) to make the 27-nation bloc "a magnet for researchers". 'Peanut butter spread' Smith and UHN's vice president for science and research, Brad Wouters, argued that Canada -- and particularly its largest city, Toronto -- are well placed to compete for US talent. English-speaking, culturally familiar, and geographically close to major US research centers in New England and New York, Toronto boasts a hospital network and research ecosystem regularly ranked among the world's best. The city has already poached three high-profile academics from Yale University, although all work in the arts. The group -- who study fascism -- announced last month in a stirring New York Times video that they were leaving the United States to take up positions in Toronto. "I'm leaving to the University of Toronto because I want to do my work without the fear that I will be punished," one of the professors, Jason Stanley, said in the video. Wouters told AFP that since Trump's election, UHN "started to see a talent pool that was a notch higher than what we normally see" for vacant positions, with leading US-based scientists initiating inquiries about opportunities in Toronto. UHN has launched a plan to create 100 medical research positions through its own fundraising but wants institutions across Canada to attract 1,000 new scientists. Reaching that target will require government support, and confronting an ingrained Canadian mindset that prioritizes sharing healthcare resources equally across the vast country. The plan will face "a bit of a collision between the peanut butter spread of equality versus elitism," Smith said. "That isn't always easy for governments or for elected we're pretty hopeful," he added. 'Supporting role' Matthew Lebo, a political scientist at Ontario's Western University, agreed Trump's policies have created an unprecedented opportunity for brain gain in Canada. But he voiced concern the country wouldn't mobilize. "Canada has a history of being comfortable playing a supporting role," he told AFP. "There is just an inherent lack of ambition." Lebo noted that while some US-based researchers may be concerned about crackdowns on their work, others might eye Canada for personal reasons, including the desire to live in a country where reproductive and LGBTQ rights are more firmly safeguarded. While he hasn't yet seen signs of broad national action, he said "it wouldn't take deep thought to catch up." "It takes some big number (of dollars) and a plan."

'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever
'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever

Sustainability Times

time06-06-2025

  • Sustainability Times

'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever

IN A NUTSHELL 🚀 Researchers discover that necrosis —a chaotic form of cell death—holds the key to enhancing human aging and space travel. —a chaotic form of cell death—holds the key to enhancing human aging and space travel. 🧬 Unlike programmed cell death, necrosis is messy and contagious , contributing to chronic diseases like Alzheimer's and cardiovascular decline. , contributing to chronic diseases like Alzheimer's and cardiovascular decline. 🔬 Targeting necrosis could unlock new treatments for age-related diseases by breaking destructive cycles and allowing for healthy cell function. 🌌 Addressing necrosis in space could mitigate accelerated aging effects on astronauts, paving the way for longer missions and deeper exploration. In a groundbreaking study, scientists have uncovered the potential role of necrosis in not only understanding human aging but also in enhancing the possibilities of deep space travel. Often dismissed as mere biological debris, necrosis—a chaotic form of unprogrammed cell death—has been revealed as a critical factor in tissue damage and systemic decline. Researchers from University College London, the biotech firm LinkGevity, and the European Space Agency argue that this understanding could pave the way for new treatments for chronic illnesses and provide a crucial tool for humans to survive in space. This discovery opens doors to revolutionary advances in medicine and space exploration. Understanding Necrosis: The Chaotic Cell Death Necrosis is a form of cell death that occurs when cells are overwhelmed by injury, infection, or stress. This process floods cells with calcium, disrupting vital functions and causing the cell to rupture. The collapse spills toxic molecules into the surrounding tissue, triggering inflammation and accelerating damage. Unlike the well-ordered process of programmed cell death, necrosis is messy—and contagious. A single dying cell can spark a chain reaction in its neighbors, compounding degeneration over time. Researchers believe this chaotic process may explain how chronic diseases such as Alzheimer's, kidney failure, and cardiovascular decline intensify with age. According to Dr. Keith Siew, necrosis has been largely overlooked as it was considered an endpoint. However, mounting evidence suggests it is a central mechanism through which systemic degeneration arises and spreads. By targeting necrosis, scientists hope to unlock new ways to treat conditions ranging from kidney failure to cardiac disease, neurodegeneration, and even aging itself. 'Einstein Was Right All Along': This Atomic Clock on the ISS Is Putting General Relativity to Its Ultimate Test Necrosis and Its Impact on Chronic Diseases Dr. Carina Kern emphasizes that necrosis is not just the last stage of cell death but a critical point of convergence across many diseases. In many age-related illnesses—affecting organs such as the lungs, kidneys, liver, brain, and cardiovascular system—relentless cascades of necrosis fuel disease progression. This often occurs alongside impaired healing, leading to fibrosis, inflammation, and damaged cells. Each cascade triggers and amplifies the next, creating a vicious cycle of degeneration. If scientists can target and manage necrosis, they could potentially transform the treatment of various chronic diseases. The key lies in breaking the destructive cycles that necrosis initiates, allowing for healthier cell function and possibly even regeneration. This approach could revolutionize the way we understand and treat degenerative conditions, offering hope for improved health outcomes in aging populations. 'Alien-Like Sea Creature Emerges': Extremely Rare Marine Species Seen for First Time Following 62-Mile Iceberg Detachment Challenges and Opportunities in Space Exploration Necrosis presents a significant obstacle to human space exploration, as astronauts endure accelerated aging caused by microgravity and cosmic radiation. A 2024 study involving Dr. Siew highlighted the rapid deterioration of kidney function in low-gravity environments, raising concerns for long-duration space missions. Professor Damian Bailey suggests that addressing necrosis could transform longevity on Earth and push the frontiers of space exploration. In space, factors that contribute to aging on Earth are exacerbated by cosmic radiation and microgravity, speeding up degeneration dramatically. If necrosis could be prevented, even temporarily, it would shut down destructive cycles at their source, enabling normal physiological processes and cell division to resume. This potential for regeneration could be a game-changer for long-term human survival in space, opening new horizons for exploration and discovery. 'Global Population Far Higher Than Expected': New Revelation Exposes Massive Undercount That Changes Everything About Our Future Future Implications and the Path Forward The study of necrosis and its implications for aging and space travel has been published in Nature Oncogene, signaling a significant step forward in understanding this complex process. The collaborative efforts of scientists from various fields underscore the importance of interdisciplinary research in tackling global challenges. As science continues to unravel the mysteries of necrosis, the potential applications in medicine and space exploration are vast and promising. With the possibility of targeting necrosis to treat chronic diseases and support human survival in space, the future of this research is both exciting and challenging. As we venture further into the unknown, what new discoveries about cell death and regeneration will shape the future of humanity, both on Earth and beyond? Our author used artificial intelligence to enhance this article. Did you like it? 4.6/5 (26)

A-ha's Morten Harket reveals he has Parkinson's disease
A-ha's Morten Harket reveals he has Parkinson's disease

Euronews

time05-06-2025

  • Euronews

A-ha's Morten Harket reveals he has Parkinson's disease

Morten Harket, frontman of celebrated Norwegian synth-pop band A-Ha, has revealed that he has Parkinson's disease. The news was shared by the band in a statement on their website which read: 'This isn't the sort of news anyone wants to deliver to the world, but here it is – Morten has Parkinson's disease.' The pop icon, aged 65, shared further details of the diagnosis in the post, and explained why he has sharing the news after previously keeping details on his health 'strictly private'. 'I've got no problem accepting the diagnosis. With time I've taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: 'I use whatever works',' he wrote. 'Part of me wanted to reveal it. Like I said, acknowledging the diagnosis wasn't a problem for me; it's my need for peace and quiet to work that has been stopping me. I'm trying the best I can to prevent my entire system from going into decline.' Harket said he underwent neurological procedures to have electrodes implanted inside his brain last year and that this had reduced the symptoms. He continued: 'It's a difficult balancing act between taking the medication and managing its side effects. There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general.' Regarding whether Harket can still perform and sing, he wrote: 'I don't really know. I don't feel like singing, and for me that's a sign. I'm broadminded in terms of what I think works; I don't expect to be able to achieve full technical control. The question is whether I can express myself with my voice. As things stand now, that's out of the question. But I don't know whether I'll be able to manage it at some point in the future.' Parkinson's is the second most common neurodegenerative disorder in the world, behind Alzheimer's. It causes deterioration in the brain's nervous system, leading to tremors and other symptoms that can become progressively worse over time. Common symptoms include involuntary shaking, slower-than-usual movement, and stiffness in the muscles. The disease can be treated with surgery and medication, but there is no cure. It is not known what exactly leads to people developing the condition. Other famous faces who have had Parkinson's diagnoses include Back To The Future actor Michael J. Fox, heavy metal legend Ozzy Osbourne and Scottish comedian Billy Connolly. In a true David versus Goliath struggle in the business world, the French conglomerate Louis Vuitton has launched an intellectual property lawsuit against the Portuguese liqueur producer, Licores do Vale. The French firm says the Monção company's use of an LV (with an inverted V) on the labels of its bottles, and a graphic for its brand's communications, are too similar to the one used by the fashion house in its productions. The action was brought before Intellectual Property Court in order to challenge the registration of the Portuguese brand by the National Institute of Industrial Property. According to the lawsuit filed and quoted by Jornal de Notícias, Louis Vuitton accuses Licores do Vale of "parasitically exploiting the prestige of a third party's brand", and creating "unfair competition" with an "identical or similar" symbol. The French giant says that it is "an almost total reproduction" at "verbal, phonetic and conceptual" level and that it has registered products in the same category, thus reinforcing the alleged similarities. A post shared by Licores do Vale (@_licores_do_vale) Licores do Vale producer, André Ferreira told Jornal de Notícias, that he developed the logo together with his girlfriend in order to promote the product at small agricultural fairs in the region. "The L is for liqueurs and the V is for valley, it was turned upside down to symbolise the mountains surrounding the parish [of Longos Vales] and the little leaves represent nature," he said. Ferreira, a metrology technician, who is trying to take his first steps in the world of artisanal production, says he was "surprised" by the measure, emphasising that the products are not on sale for now. "This is a hobby. We've only just begun and started straight away with this entry. The Louis Vuitton logo and the Licores do Vale logo have nothing to do with each other." Ferreira applied to register the trade mark in August 2024 and it was granted in January 2025. At the time, Louis Vuitton "prioritised international trademark registrations", with no consequences for the small Portuguese producer, who saw his application accepted. Even so, and despite the registration having been approved, the legal appeal now lodged by Louis Vuitton puts that registration on hold, leaving "Licores do Vale" in limbo. On social media, particularly Instagram, many users have shown their support for the small Portuguese producer, encouraging him to continue his business and even to take advantage of the media coverage generated by the case. On Instagram, where liqueurs of different flavours are discussed, the small business has just over 1,000 followers. Louis Vuitton, a French brand with 170 years of history, has more than 55 million followers on Instagram alone.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store